Hundreds die from deadly bacteria in Israel

Mar 07, 2007

Doctors said an antibiotic-resistant bacterium known as Klebsiella pneumoniae has killed as many as 200 patients in hospitals across Israel.

Elderly patients and people with weak immune systems are particularly vulnerable to the bacterium, Arutz Sheva reported.

Epidemiologist Yehuda Carmeli of the Sourasky Medical Center in Tel Aviv said 400 to 500 people have been infected by the bug.

"Thirty to forty percent of them have already died," Carmeli told YNetNews. "However, it is important to note that most of them were in a serious condition, and some were suffering from prior medical conditions."

Infectious diseases specialist Dr. Galia Rahav told Israel's Channel 1 that 130 patients at Sheba Hospital have become infected. One-third of those patients have died.

YNetNews said the Israeli Health Ministry has set up a committee of experts to "determine the scope of the problem and advise hospitals on how to contain it."

Copyright 2007 by United Press International

Explore further: Research shows that bacteria survive longer in contact lens cleaning solution than thought

add to favorites email to friend print save as pdf

Related Stories

The DNA thief

May 31, 2013

Evolutionarily speaking, we humans are doing pretty well. Over the last few million years, we've developed big brains, social structures and more recently, culture, cities, philosophy, airplanes and the Internet. ...

Birds may spread, not halt, fever-bearing ticks

Nov 30, 2012

Turkey raises and releases thousands of non-native guineafowl to eat ticks that carry the deadly Crimean-Congo hemorrhagic fever virus. Yet research suggests guineafowl eat few ticks, but carry the parasites ...

No slowdown in sight for cyber attacks, experts say

Jul 31, 2012

Cyber attacks are accelerating at a pace that suggests the Internet - already a risky environment - is likely to pose a steadily growing threat to individuals and companies for years to come.

Amgen posts higher 2Q sales, profit to beat views

Jul 27, 2012

(AP) — Amgen Inc.'s second-quarter net income rose 8 percent as the world's largest biotech company benefited from higher sales for its top-selling drugs and a gain from selling its share of an experimental medicine.

Recommended for you

Ebola virus in Africa outbreak is a new strain

12 hours ago

The Ebola virus that has killed scores of people in Guinea this year is a new strain—evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.

Researchers see hospitalization records as additional tool

13 hours ago

Comparing hospitalization records with data reported to local boards of health presents a more accurate way to monitor how well communities track disease outbreaks, according to a paper published April 16 in the journal PLOS ON ...

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Sony's PlayStation 4 sales top seven million

Sony says it has sold seven million PlayStation 4 worldwide since its launch last year and admitted it can't make them fast enough, in a welcome change of fortune for the Japanese consumer electronics giant.